Navigation Links
CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
Date:5/29/2012

KING OF PRUSSIA, Pa., May 29, 2012 /PRNewswire/ -- CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review its Biologics License Application (BLA) for a human 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of vitamin K-antagonist therapy (i.e., warfarin) in patients with acute major bleeding. If approved by the FDA, the CSL Behring 4-factor PCC would be the first agent of its kind available in the United States.

"The acceptance by FDA of this 4-factor PCC BLA marks an important step toward addressing the urgent unmet need for a rapid and simple way to reverse the effects of warfarin during bleeding emergencies," said Val Romberg, Senior Vice President, Research and Development at CSL Behring. "This 4-factor PCC has the potential to be a significant new tool in stopping excessive bleeding in patients on warfarin, where fresh frozen plasma is the current standard of care."

The CSL Behring BLA submission is based on results from three prospective Phase III clinical trials that evaluated the safety and efficacy of PCC in patients who required urgent reversal of warfarin therapy. The pivotal, acute major bleeding trial demonstrated that PCC was comparable to plasma at 24 hours in patients who required urgent reversal of warfarin therapy (72.4 percent and 65.4 percent, respectively). Additionally, the co-primary efficacy endpoint analysis showed that the 4-factor PCC was superior in achieving target INR correction within 30 minutes at the end of infusion as compared to plasma (62.2 percent and 9.6 percent, respectively). Four-factor PCC was also superior to plasma in rapidly and safely raising the levels of clotting factors II, VII, IX, X, and anticoagulant Proteins C and S at the same 30 minutes post-treatment time point (p values<0.0001).

About Prothrombin Complex Concentrate (PCC) (Human)

Prothrombin compl
'/>"/>

SOURCE CSL Behring
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
2. CSL Behring Renews Pledge to Provide Significant Funding and Donated Coagulation Factor to World Federation of Hemophilia Over 3-Year Period
3. CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
4. CSL Behring Recognized as a "Pioneer" By European Organisation for Rare Diseases (EURORDIS)
5. First Patient Screened in CSL Behring Global Phase I/III Study of Recombinant Single-Chain Factor VIII
6. CSL Behring Receives FDA Orphan Drug Designation for rVIIa-FP, a Novel Therapy in Development to Treat Hemophilia A and Hemophilia B Patients Who Have Inhibitors
7. CSL Behring Receives FDA Approval of Expanded Label on Berinert® for Self-administration and Treatment of Acute Laryngeal Attacks of Hereditary Angioedema
8. CSL Behring Seeks Proposals for Interlaken Leadership Awards, Supporting Innovative Research Into Neuroimmunology
9. CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment
10. National Organization for Rare Disorders Presents CSL Behring With 2011 Corporate Award
11. CSL Behring Marks World Hemophilia Day with Coagulation Factor Donation to World Federation of Hemophilia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Ill. and MECHELEN, Belgium ... GLPG) and AbbVie (NYSE: ABBV ) announced ... to include Crohn,s disease.  Galapagos will fund and complete ... designed to facilitate rapid progression into Phase 3.  Upon ... AbbVie will pay Galapagos $50 million.  The terms of ...
(Date:5/16/2013)... FRAMINGHAM, Mass. and SYDNEY , ... HTWR - ASX: HIN), a leading innovator of less ... of advanced heart failure, today announced that CEO ... 2013 UBS Global Healthcare Conference at 11:00 a.m. EDT on ... 20-22, 2013 at the Sheraton New York Hotel. ...
(Date:5/16/2013)... -- OrthoView PSL will allow individual surgeons ... widely-used OrthoView digital templating software via the Cloud and ... started. OrthoView, the leading independent provider of ... dedicated to enabling orthopaedic surgeons in hospitals and private ... film is unavailable. Over 5,000 orthopaedic surgeons in the ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
... 24, 2011 Reportlinker.com announces that a new ... Global Cardiac Defibrillators Industry ... report analyzes the worldwide markets for Cardiac Defibrillators ... the US markets is analyzed by the following ...
... YORK, Feb. 24, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p090668/Global-Biotechnology-Instrumentation-Industry.html This ... Instrumentation in US$ Million by the following ...
Cached Medicine Technology:Reportlinker Adds Global Cardiac Defibrillators Industry 2Reportlinker Adds Global Biotechnology Instrumentation Industry 2
(Date:5/18/2013)... Bay, CA (PRWEB) May 18, 2013 ... , has recently completed a stylish renovation that features ... advanced specialties. , From the ground up, this ... improved with fresh flooring, soothing colors and comfortable spa ... been installed, including an Apilus epilator machine. The ...
(Date:5/18/2013)... Dr. Robert Tracey, an area leader in dental ... knowledge of the root causes of sleep apnea to provide ... Better Sleep Month, Dr. Tracey points out estimates revealing that ... and sleep apnea is one of the most common of ... stop breathing at different times while sleeping. When this happens, ...
(Date:5/18/2013)... 2013 The topics that will be covered ... scrum roles, scrum meetings, scrum artifacts, and scrum simulation (optional). ... attending them. , These trainings are suitable for business analysts, ... for those who will be a part of the Scrum ... to explore Agile and Scrum, but are unsure of what ...
(Date:5/18/2013)... May 18, 2013 Kimono condoms ... America’s favorite condom store recently announced. Condomania recently ... store's large selection of condoms from all over the ... it easy to try different condom styles from one ... Featuring Kimono’s classic comfortable shape and secure, the new ...
(Date:5/18/2013)... 18, 2013 Medical device company, FlexLeg, LLC, ... much anticipated mobility aid with its namesake, the FlexLeg. ... crutch alternative that injured individuals can use to ... example, can remain active and walk during a typical 6-8 ... reservation system to ensure those who need the device most ...
Breaking Medicine News(10 mins):Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3Health News:Kimono Condoms Assorted Sampler Packs Now Available at Condomania 2Health News:FlexLeg Begins Offering New Mobility Aid 2
... ... Hormonal health is a struggle for women of all ages. Despite the ... something non-synthetic for symptomatic relief of menstrual and menopausal woes. Garden of ... is providing women of all ages a natural way to balance hormones ...
... Laurence Barsh, DMD spoke at ... 2009 on the subject of educating the public about dentistry,s role in the management of snoring ... New York, NY ... Sleep Medicine in Seattle on June 5, 2009 on the subject of educating the public about ...
... The following statement was issued Wednesday, June 10, ... M. Pavlinac, following a press conference by U.S. Sen. ... menu labeling to be included in the Senate,s Committee ... reform legislation. , , "The American Dietetic Association ...
... Allscripts announced today that its 3.50 percent Convertible ... at the option of the holders of the Debentures ... August 31, 2009. Any determinations regarding the convertibility ... in accordance with the terms of the indenture under ...
... June 10 IPC The Hospitalist Company, Inc. (Nasdaq: ... that management is scheduled to present at the Jefferies 3rd Annual ... City. Adam Singer, M.D., Chairman and CEO, and Jeff Taylor, ... presentation will take place at 3:15 P.M. Eastern time on Thursday, ...
... /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) ... appointed Vice President Finance & Administration and Chief Financial ... experience in several industries. , "Following the Annual General ... to recognize Livleen for her outstanding financial leadership in ...
Cached Medicine News:Health News:MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3&#8482; Healthy Hormones&#8482; 2Health News:MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3&#8482; Healthy Hormones&#8482; 3Health News:MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3&#8482; Healthy Hormones&#8482; 4Health News:Founder of Snoring Isn't Sexy, LLC Addresses Annual Meeting of the American Academy of Dental Sleep Medicine 2Health News:Statement by American Dietetic Association Supporting Scientifically Valid, Informative Restaurant Labeling as Part of Health Reform 2Health News:Allscripts Announces Convertibility of its Outstanding 3.50 Percent Senior Debentures 2Health News:Allscripts Announces Convertibility of its Outstanding 3.50 Percent Senior Debentures 3Health News:Allscripts Announces Convertibility of its Outstanding 3.50 Percent Senior Debentures 4Health News:IPC The Hospitalist Company, Inc. to Present at Jefferies 3rd Annual Healthcare Conference 2Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 2Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 3Health News:Response Biomedical Corporation Announces Appointment of Vice President Finance & Administration and Chief Financial Officer 4
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Severe revision options for the knee and hip...
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products: